Abdulrahman A. Halwani
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems 6
- Advancements in Transdermal Drug Delivery 2
- Drug Solubulity and Delivery Systems 2
- Biomaterials top 10%
- Electrospun Nanofibers in Biomedical Applications 4
- Nanoparticle-Based Drug Delivery 2
-
- Innovative Microfluidic and Catalytic Techniques Innovation 2
-
- Wound Healing and Treatments 2
-
- Adenosine and Purinergic Signaling 2
- Co-authors
- Essam A. TawfikKhaled M. HosnyBarkat Ali KhanMoutaz Y. BadrMuhammad Khalid KhanSamar S. A. MurshidRana B. BakhaidarHaitham A. Bukhary
- Journals
- International Journal of Pharmaceutics (2 papers)International Journal of Nanomedicine (1 paper)Polymers (1 paper)
- Partner nations
- Saudi ArabiaUnited StatesPakistan
In The Last Decade
Abdulrahman A. Halwani
16 papers receiving 414 citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Pharmaceutical Science 92
- Biomaterials 132
- Molecular Medicine 19
- Applied Microbiology and Biotechnology 5
- Biomedical Engineering 104
Countries citing papers authored by Abdulrahman A. Halwani
This map shows the geographic impact of Abdulrahman A. Halwani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdulrahman A. Halwani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdulrahman A. Halwani more than expected).
Fields of papers citing papers by Abdulrahman A. Halwani
This network shows the impact of papers produced by Abdulrahman A. Halwani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdulrahman A. Halwani. The network helps show where Abdulrahman A. Halwani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Abdulrahman A. Halwani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 4 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 3 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 37 | |
| 7 | 2022 | 13 | |
| 8 | 2022 | 10 | |
| 9 | 2022 | 14 | |
| 10 | 2022 | 7 | |
| 11 | 2022 | 37 | |
| 12 | Development of Pharmaceutical Nanomedicines: From the Bench to the Marketbreakdown → | 2022 | 206 |
| 13 | 2022 | 5 | |
| 14 | 2021 | 29 | |
| 15 | 2021 | 30 | |
| 16 | 2017 | 16 |
About Abdulrahman A. Halwani
Abdulrahman A. Halwani is a scholar working on Pharmaceutical Science, Applied Microbiology and Biotechnology and Biomaterials, having authored 16 papers that have together received 419 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (6 papers), Electrospun Nanofibers in Biomedical Applications (4 papers), Innovative Microfluidic and Catalytic Techniques Innovation (2 papers), Advancements in Transdermal Drug Delivery (2 papers), Drug Solubulity and Delivery Systems (2 papers), Wound Healing and Treatments (2 papers), Adenosine and Purinergic Signaling (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). The work is most often cited by research in Pharmaceutical Science (92 citations), Biomaterials (132 citations) and Molecular Medicine (19 citations). Abdulrahman A. Halwani has collaborated with scholars based in Saudi Arabia, United States and Pakistan. Frequent co-authors include Essam A. Tawfik, Khaled M. Hosny, Barkat Ali Khan, Moutaz Y. Badr, Muhammad Khalid Khan, Samar S. A. Murshid, Rana B. Bakhaidar, Haitham A. Bukhary, Alhassan H. Aodah and Abdullah A. Alshehri. Their work appears in journals such as International Journal of Pharmaceutics, International Journal of Nanomedicine and Polymers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.